Bio-Response Sale
- Share via
United Press International
HAYWARD, Calif. — Bio-Response Inc. said it has reached a definitive agreement to sell its assets to Baxter Healthcare Corp. for about $9 million in cash.
Proceeds from the sale will be used to pay creditors, Bio-Response said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
